Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 974

NCT06948422

ArmPopulationDoseWeeksEstimandWeight change
Orforglipron (GZL1)Hypertensionn/rn/rn/rn/r
Orforglipron (GZL2)Hypertensionn/rn/rn/rn/r